TickerKhojComparison · NSE · data 2026-11-03
Hester Biosciences Limited vs Windlas Biotech Ltd.
In plain words
Size: Hester Biosciences Limited is about 1.1 times the market value of Windlas Biotech Ltd..
Valuation (P/E): Windlas Biotech Ltd. 29.1 vs Hester Biosciences Limited 14.2.
Return on equity: Hester Biosciences Limited 16.5% vs Windlas Biotech Ltd. 12.2%.
Profit growth over 3 years: Hester Biosciences Limited 27.8% a year vs Windlas Biotech Ltd. 16% a year.
Debt to equity: Hester Biosciences Limited 0.54 vs Windlas Biotech Ltd. 0.06.
Differences in the numbers, not a recommendation of either stock.
Side by side
| HESTERBIO | WINDLAS | |
|---|---|---|
| Price | ₹2,278.7 | ₹909.65 |
| Market cap | ₹1,956 cr | ₹1,810 cr |
| P/E | 14.2 | 29.1 |
| P/B | — | — |
| ROE | 16.5% | 12.2% |
| ROCE | 13.0% | 13.5% |
| Debt / equity | 0.54 | 0.06 |
| Operating margin | 19.9% | 7.9% |
| Dividend yield | 0.48% | 0.72% |
| Sales growth, 3 years (yearly) | 7.7% | 20.8% |
| Profit growth, 3 years (yearly) | 27.8% | 16.0% |
| 1-year return | 42.2% | -3.9% |
| Revenue, last 12 months | ₹326 cr | ₹942 cr |
| Net profit, last 12 months | ₹136 cr | ₹66 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹97 cr | ₹18 cr |
| Quarter profit vs a year earlier | +489.9% | -0.1% |
| Promoter holding | 44.28% | 63.31% |
| Health check | Strong (8.4/10) | Strong (6.8/10) |
Common questions
Which has a higher P/E, Hester Biosciences Limited or Windlas Biotech Ltd.?
Windlas Biotech Ltd. trades at the higher P/E (29.1 against 14.2). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Hester Biosciences Limited (16.5% against 12.2%).
Which carries more debt?
Hester Biosciences Limited has the higher debt-to-equity ratio (0.54 against 0.06).